Intravenous rt-PA for acute ischemic stroke: 69 Consecutive patients managed in an emergency stroke centre;Évaluation à 4 ans de la filière «Urgences AVC» de l'Hôpital Purpan (Toulouse) et analyse de 69 patients conścutifs traités par rt-PA intra-veineux

Revue Neurologique

Volumn 163, Issue 3, 2007, Pages 349-357

  Tardy, J ^a   Albucher, J F ^a   Pariente J ^a   Chollet, F ^a  

^a CHU PURPAN   (France)

Author keywords

rt P; Stroke emergency pathway; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMA; COMPUTER ASSISTED TOMOGRAPHY; DECEREBRATION; EMERGENCY CARE; EVALUATION; HOSPITAL ADMISSION; HUMAN; MEDICAL PRACTICE; ONSET AGE; RANKIN SCALE; SIDE EFFECT; EMERGENCY HEALTH SERVICE; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PATIENT SELECTION; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33947572463     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90407-5     Document Type: Article

References (27)

1. ADAMS H, ADAMS R, DEL ZOPPO G, GOLDSTEIN LB. (2005). Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke, 36: 916-923.
2. ALBERS GW, BATES VE, CLARK WM, BELL R, VERRO P, HAMILTON SA. (2000). Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Jama, 283: 1145-1150.
3. CHAPMAN KM, WOOLFENDEN AR, GRAEB D et al. (2000). Intravenous tissue plasminogen activator for acute ischemic stroke: A Canadian hospital's experience. Stroke, 31: 2920-2924.
4. CORNU C, BOUTITIE F, CANDELISE L et al. (2000). Streptokinase in acute ischemic stroke: an individual patient data meta-analysis: The Thrombolysis in Acute Stroke Pooling Project. Stroke, 31: 1555-1560.
5. DEREX L, NIGHOGHOSSIAN N, HERMIER M et al. (2004). Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis, 17: 238-241.
6. GRAHAM GD. (2003). Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke, 34: 2847-2850.
7. GROND M, STENZEL C, SCHMULLING S et al. (1998). Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke, 29: 1544-1549.
8. HACKE W, ALBERS G, AL-RAWI Y et al. (2005). The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke, 36: 66-73.
9. HACKE W, DONNAN G, FIESCHI C et al. (2004). Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet, 363: 768-774.
10. HACKE W, KASTE M, FIESCHI C et al. (1995). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Jama, 274: 1017-1025.
11. HACKE W, KASTE M, FIESCHI C et al. (1998). Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet, 352: 1245-1251.
12. HALEY EC, LYDEN PD, JOHNSTON KC, HEMMEN TM. (2005). A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke, 36: 607-612.
13. HILL MD, BUCHAN AM. (2005). Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. Cmaj, 172: 1307-1312.
14. KAKUDA W, THIJS VN, LANSBERG MG et al. (2005). Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology, 65: 1175-1178.
15. KATZAN IL, FURLAN AJ, LLOYD LE et al. (2000). Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. Jama, 283: 1151-1158.
16. KATZAN IL, HAMMER MD, FURLAN AJ, HIXSON ED, NADZAM DM. (2003). Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke, 34: 799-800.
17. KIDWELL CS, SAVER JL, VILLABLANCA JP et al. (2002). Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke, 33: 95-98.
18. LARRUE V, AMARENCO P, CAUSSANEL J et al. (2000). Recommandations pour l'utilisation du traitement thrombolytique intraveineux dans l'accident ischémique cérébral. Rev Neurol, 156 : 1178-1185.
19. NINDS. (1995). Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med, 333: 1581-1587.
20. QURESHI AI, KIRMANI JF, SAYED MA et al. (2005a). Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology, 64: 2115-2120.
21. QURESHI AI, SURI MF, NASAR A et al. (2005b). Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001. Neurosurgery, 57: 647-654.
22. REED SD, CRAMER SC, BLOUGH DK, MEYER K, JARVIK JG. (2001). Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke, 32: 1832-1840.
23. SAPOSNIK G, DI LEGGE S, WEBSTER F, HACHINSKI V. (2005). Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology, 65: 1169-1174.
24. WANG DZ, ROSE JA, HONINGS DS, GARWACKI DJ, MILBRANDT JC. (2000). Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke, 31: 77-81.
25. WARDLAW JM, SANDERCOCK PA, BERGE E. (2003). Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke, 34: 1437-1442.
26. WEIMAR C, GLAHN J, VON REUTERN GM, KLOTH A, BUSSE O, DIENER HC. (2002). Treatment of ischemic stroke in 14 neurologic stroke units. An evaluation of the stroke databank of the German Stroke Aid Foundation. Nervenarzt, 73: 342-348.
27. WOJNER-ALEXANDROV AW, ALEXANDROV AV, RODRIGUEZ D, PERSSE D, GROTTA JC. (2005). Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke, 36: 1512-1518.